Breast Implant ALCL Lawsuits Continue To Mount As New Cases of Cancer Diagnosed
Women continue to file breast implant ALCL lawsuits two years after Allergan's Biocell implants were recalled due to the appearance of newly-diagnosed cases.
Women continue to file breast implant ALCL lawsuits two years after Allergan's Biocell implants were recalled due to the appearance of newly-diagnosed cases.
The FDA has announced new safety requirements for breast implants, including a patient checklist, a black box warning, and screening requirements for silicone gel ruptures.
The FDA is seeking input on how it can improve medical implant labeling to warn patients of potential adverse reactions to the materials used in those devices, following problems with…
Allergan faces an increasing number of breast implant lawsuits over the link between its Biocell textured breast implants and a rare form of lymphoma.
The FDA warns some surgical mesh being used off-label in breast reconstruction may cause a high rate of complications, infections and the need for revision surgery and breast implant removal.
A recent study found that almost all cases of breast implant lymphoma are linked to Allergan Biocell implants, and virtually all cases are resolved by removing the implant and surrounding…
Allergan and a Louisiana woman have reached a settlement agreement about a breast implant which she had removed after it began leaking and causing pain.
A new study suggest breast implants may cause chronic inflammation which interferes with a process connected to cell growth and survival, resulting in an increased risk of cancer.
Biocell breast implant lawsuit discovery has been paused until the federal judge presiding over the cases resolves a motion seeing to dismiss the litigation.
A case report highlights the risk of a little-known aggressive, and deadlier, form of breast implant lymphoma.